Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Oral Navelbine in Female Patients With HER2-Negative Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of oral Navelbine in HER2-negative metastatic breast cancer in female patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Navelbine (vinorelbine)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Phase 2 | Status: UNKNOWN